Publications

1. Klingspor L, Loeffler J. Aspergillus PCR formidable challenges and progress. Med Mycol 2009; 47 Suppl 1: S241-7.

2. Mengoli C, Cruciani M, Barnes RA, Loeffler J, Donnelly JP. Use of PCR for diagnosis of invasive aspergillosis: systematic review and meta-analysis. Lancet Infect Dis 2009; 9(2): 89-96.

3. White PL, Bretagne S, Klingspor L, et al. Aspergillus PCR: one step closer to standardization. J Clin Microbiol 2010; 48(4): 1231-40.

4. White PL, Perry MD, Loeffler J, et al. Critical stages of extracting DNA from Aspergillus fumigatus in whole-blood specimens. J Clin Microbiol 2010; 48(10): 3753-5.

5. White PL, Mengoli C, Bretagne S, et al. Evaluation of Aspergillus PCR protocols for testing serum specimens. J Clin Microbiol 2011; 49(11): 3842-8.

6. Loeffler J, Barnes R, Donnelly JP, European Aspergillus PCRI. Standardization of Aspergillus PCR diagnosis. Bone Marrow Transplant 2012; 47(2): 299-300.

7. White PL, Loeffler J, Barnes RA, Donnelly JP. Towards a standard for Aspergillus PCR – requirements, process and results. Infectio 2012; 16 (Supl 3): 64-72.

8. Lyon GM, Abdul-Ali D, Loeffler J, et al. Development and evaluation of a calibrator material for nucleic acid-based assays for diagnosing aspergillosis. J Clin Microbiol 2013; 51(7): 2403-5.

9. White PL, Parr C, Thornton C, Barnes RA. Evaluation of real-time PCR, galactomannan enzyme-linked immunosorbent assay (ELISA), and a novel lateral-flow device for diagnosis of invasive aspergillosis. J Clin Microbiol 2013; 51(5): 1510-6.

10. Arvanitis M, Ziakas PD, Zacharioudakis IM, Zervou FN, Caliendo AM, Mylonakis E. PCR in diagnosis of invasive aspergillosis: a meta-analysis of diagnostic performance. J Clin Microbiol 2014; 52(10): 3731-42.

11. White PL, Hibbitts SJ, Perry MD, et al. Evaluation of a commercially developed semiautomated PCR-surface-enhanced raman scattering assay for diagnosis of invasive fungal disease. J Clin Microbiol 2014; 52(10): 3536-43.

12. Cruciani M, Mengoli C, Loeffler J, et al. Polymerase chain reaction blood tests for the diagnosis of invasive aspergillosis in immunocompromised people. Cochrane Database Syst Rev 2015; 9(9): CD009551.

13. Cruciani M, Mengoli C, Loeffler J, Donnelly P, Barnes R, Jones BL, et al. Polymerase chain reaction blood tests for the diagnosis of invasive aspergillosis in immunocompromised people. Cochrane Database Syst Rev. 2015(10):CD009551.
    
    
14. Loeffler J, Mengoli C, Springer J, et al. Analytical Comparison of In Vitro-Spiked Human Serum and Plasma for PCR-Based Detection of Aspergillus fumigatus DNA: a Study by the European Aspergillus PCR Initiative. J Clin Microbiol 2015; 53(9): 2838-45.
    
    
15. White PL, Barnes RA, Springer J, et al. Clinical Performance of Aspergillus PCR for Testing Serum and Plasma: a Study by the European Aspergillus PCR Initiative. J Clin Microbiol 2015; 53(9): 2832-7.

16. White PL, Donnelly JP, Barnes RA. Developments in the molecular diagnosis of Invasive Fungal Disease. E-Chapter in Invasive Fungal Infections in Cancer Patients. Ed. H Akhan. Turkish Febrile Neutropenia Society. 2015. In: Akhan H. Invasive Fungal Infections in Cancer Patients: Turkish Febrile Neutropenia Society, 2015.

17. White PL, Wingard JR, Bretagne S, et al. Aspergillus Polymerase Chain Reaction: Systematic Review of Evidence for Clinical Use in Comparison With Antigen Testing. Clin Infect Dis 2015; 61(8): 1293-303.

18. Morton CO, White PL, Barnes RA, et al. Determining the analytical specificity of PCR-based assays for the diagnosis of IA: What is Aspergillus? Medical Mycology 2016: myw093.

19. Springer J, White PL, Hamilton S, et al. Comparison of Performance Characteristics of Aspergillus PCR in Testing a Range of Blood-Based Samples in Accordance with International Methodological Recommendations. J Clin Microbiol 2016; 54(3): 705-11.

20. White PL, Wiederhold NP, Loeffler J, et al. Comparison of Nonculture Blood-Based Tests for Diagnosing Invasive Aspergillosis in an Animal Model. J Clin Microbiol 2016; 54(4): 960-6.

21. Morton CO, White PL, Barnes RA, Klingspor L, Cuenca-Estrella M, Lagrou K, et al. Determining the analytical specificity of PCR-based assays for the diagnosis of IA: What is Aspergillus? Med Mycol. 2017;55(4):402-13.

22. Springer J, Loffler J. Genus- and Species-Specific PCR Detection Methods. Methods Mol Biol. 2017;1508:267-79.

23. Barnes RA, White PL, Morton CO, et al. Diagnosis of aspergillosis by PCR: Clinical considerations and technical tips. Med Mycol 2018; 56(suppl_1): 60-72.

24. Cruciani M, Mengoli C, Barnes R et al. Polymerase chain reaction blood tests for the diagnosis of invasive aspergillosis in immunocompromised people. Cochrane Database Syst Rev. 2019 Sep 3;9:CD009551.

25. Delliere S, Gits-Muselli M, White PL, Mengoli C, Bretagne S, Alanio A. Quantification of Pneumocystis jirovecii: Cross-Platform Comparison of One qPCR Assay with Leading Platforms and Six Master Mixes. J Fungi (Basel). 2019;6(1).
    
    
26. Patterson TF, Donnelly JP. New Concepts in Diagnostics for Invasive Mycoses: Non-Culture-Based Methodologies. J Fungi (Basel). 2019;5(1).
    
    
27. White PL, Barnes RA, Gorton R, Cruciani M, Loeffler J, Fungal PCRI. Comment on: T2Candida MR as a predictor of outcome in patients with suspected invasive candidiasis starting empirical antifungal treatment: a prospective pilot study. J Antimicrob Chemother 2019; 74(2): 532-3.
    
    
28. Donnelly JP, Chen SC, Kauffman CA, et al. Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium. Clin Infect Dis 2020; 71(6): 1367-76.
    
    
29. Gits-Muselli M, White PL, Mengoli C, et al. The Fungal PCR Initiative’s evaluation of in-house and commercial Pneumocystis jirovecii qPCR assays: Toward a standard for a diagnostics assay. Med Mycol 2020; 58(6): 779-88.
    
    
30. Springer J, Löffler J, Einsele H, White PL. The screening of blood by Aspergillus PCR and galactomannan ELISA precedes BAL detection in patients with proven and probable IA. Medical Mycology 2020; 58(6): 856-8.
    
    
31. Cruciani M, White PL, Mengoli C, Loffler J, Morton CO, Klingspor L, et al. The impact of anti-mould prophylaxis on Aspergillus PCR blood testing for the diagnosis of invasive aspergillosis. J Antimicrob Chemother. 2021;76(3):635-8.

32. Rocchi S, Scherer E, Mengoli C, et al. Interlaboratory evaluation of Mucorales PCR assays for testing serum specimens: A study by the fungal PCR Initiative and the Modimucor study group. Med Mycol 2021; 59(2): 126-38.
    
    
33. White PL, Bretagne S, Caliendo AM, et al. Aspergillus Polymerase Chain Reaction-An Update on Technical Recommendations, Clinical Applications, and Justification for Inclusion in the Second Revision of the EORTC/MSGERC Definitions of Invasive Fungal Disease. Clin Infect Dis 2021; 72(Suppl 2): S95-S101.
    
    
34. White PL, Alanio A, Brown L, Cruciani M, Hagen F, Gorton R, et al. An overview of using fungal DNA for the diagnosis of invasive mycoses. Expert Rev Mol Diagn. 2022;22(2):169-84.

35. Cruciani M, White PL, Barnes RA, et al. An Overview of Systematic Reviews of Polymerase Chain Reaction (PCR) for the Diagnosis of Invasive Aspergillosis in Immunocompromised People: A Report of the Fungal PCR Initiative (FPCRI)-An ISHAM Working Group. J Fungi (Basel) 2023; 9(10).
    
    
36. Brown L, Cruciani M, Donnelly JP, Rautemaa-Richardson R, White PL. PCR diagnosis of Pneumocystis pneumonia. Clin Infect Dis 2024.
    
    
37. Brown L, Rautemaa-Richardson R, Mengoli C, et al. Polymerase Chain Reaction on Respiratory Tract Specimens of Immunocompromised Patients to Diagnose Pneumocystis Pneumonia: A Systematic Review and Meta-analysis. Clin Infect Dis 2024.